“Sglt2 Inhibitors And The Clinical Conundrum Of Heart Failure With Preserved Ejection Fraction”, Journal of Pharmaceutical Negative Results, pp. 2200–2204, Nov. 2022, doi: 10.47750/pnr.2022.13.S04.273.